Daniel Faga
President, CEO at AnaptysBio; President, CEO at First Tracks Biotherapeutics. Based in San Diego, California.
- Rank
- 2928th of 14,644
- Companies held
- 2
- Largest holding
- ANAB, 85.4% of total
- Latest SEC filing
- Nov 1, 2026
What the $41.3M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| AnaptysBio ANAB Common Stock | Directly | 743,948 split-adjusted | $47.40 | $35.3M | 85.4% | Form 4, Mar 27, 2026 |
| First Tracks Biotherapeutics TRAX Common Stock | Directly | 136,000 | $44.46 | $6.0M | 14.6% | Form 4, Nov 1, 2026 |
Share counts are the amounts Daniel Faga reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Open-market trades, last 12 months
| Date | Trade | Company | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Mar 27, 2026 | Sold | ANAB | 100 | $65.99 | $7K | View |
| Mar 27, 2026 | Sold | ANAB | 3,038 | $65.20 | $198K | View |
| Mar 27, 2026 | Sold | ANAB | 3,155 | $64.19 | $203K | View |
| Mar 27, 2026 | Sold | ANAB | 2,592 | $63.35 | $164K | View |
| Mar 27, 2026 | Sold | ANAB | 1,012 | $62.15 | $63K | View |
| Mar 27, 2026 | Sold | ANAB | 550 | $60.63 | $33K | View |
| Mar 27, 2026 | Sold | ANAB | 490 | $59.62 | $29K | View |
| Mar 27, 2026 | Sold | ANAB | 3,662 | $58.62 | $215K | View |
| Mar 27, 2026 | Sold | ANAB | 510 | $56.61 | $29K | View |
| Mar 27, 2026 | Sold | ANAB | 2,570 | $57.91 | $149K | View |
| Jan 8, 2026 | Sold | ANAB | 14,281 | $44.71 | $639K | View |
| Jan 7, 2026 | Sold | ANAB | 9,202 | $45.11 | $415K | View |
| Jan 5, 2026 | Sold | ANAB | 15,309 | $43.26 | $662K | View |
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 2925 | Samuel Kintz PRESIDENT AND CEO, Enliven Therapeutics. Boulder, CO | $41.3M |
| 2926 | Alice L. Jolla Chief Accounting Officer, Microsoft. Redmond, WA | $41.3M |
| 2927 | Richard K. Crumly Director, XPEL. San Antonio, TX | $41.3M |
| 2928 | Daniel Faga President, CEO, AnaptysBio. San Diego, CA | $41.3M |
| 2929 | Shai Shalev-Shwartz Chief Technology Officer, Mobileye Global | $41.3M |
| 2930 | Kurt James Wolf President & CEO, Pitney Bowes. Shelton, CT | $41.3M |
| 2931 | Maria S. Eitel Director, Cloudflare. San Francisco, CA | $41.3M |
Other AnaptysBio insiders
All ANAB insiders- John P. Schmid$2.6MDirector. #11064 overall
Questions
How much stock does Daniel Faga own?
Daniel Faga holds $41,309,672 in listed stock based on SEC filings and current prices, mostly AnaptysBio (ANAB). That ranks 2928th on the Stock Rich List.
Is this Daniel Faga's net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.
When did Daniel Faga last buy or sell stock?
The most recent open-market trade on file is a sale of 100 ANAB shares on Mar 27, 2026 at $65.99.